Watchlist Price Alert

Mereo BioPharma Group (MREO)

NASDAQ: MREO · Real-Time Price · USD

2.80

0.04 (1.45%)

At close: Jun 17, 2025, 2:13 PM

Mereo BioPharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	69.8M	57.42M	56.33M	94.3M	23.47M	16.35M	25.04M	50.04M	53.58M
Short-Term Investments	n/a	n/a	51.1M	569K	547K	544K	2.5M	2.5M	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	-25.95M	-27.09M	-33.22M	-56.01M	n/a	n/a	n/a
Receivables	3.25M	3.73M	2.75M	1.42M	1.02M	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	-2.67M	-1.82M	-4.64M	-11.98M	-293.33K	-2.5M	-53.92M
Other Current Assets	507K	1.98M	1.43M	2.23M	n/a	n/a	5.89M	8.66M	6.1M
Total Current Assets	74.76M	63.76M	62.13M	99.32M	29.73M	30.43M	34.5M	63.18M	60.78M
Property-Plant & Equipment	984K	1.65M	1.83M	2.53M	1.57M	11.56M	148.94K	153.36K	173.87K
Goodwill & Intangibles	643K	1.09M	24.12M	24.56M	31.65M	44.46M	32.63M	33.01M	25.81M
Total Long-Term Assets	1.63M	2.74M	25.95M	27.09M	33.22M	56.01M	32.78M	33.16M	25.99M
Total Assets	76.39M	66.5M	88.08M	126.42M	62.95M	86.45M	67.28M	96.34M	86.76M
Account Payables	2.44M	2.35M	3.49M	2.29M	2.94M	5.88M	5.57M	2.64M	1.23M
Deferred Revenue	n/a	n/a	n/a	8.37M	n/a	5.45M	-177.71K	-163.72K	n/a
Short-Term Debt	5.54M	n/a	11.02M	n/a	n/a	15.14M	6.84M	1.94M	n/a
Other Current Liabilities	2.87M	2.37M	5.82M	5.62M	3.55M	684K	-2.09M	3.67M	-750.31K
Total Current Liabilities	13.85M	9.49M	24.68M	12.54M	8.56M	29.88M	16.18M	9.62M	3.21M
Long-Term Debt	n/a	4.39M	n/a	n/a	16.14M	7.04M	14.65M	18.81M	3.13M
Other Long-Term Liabilities	1.39M	1.18M	54K	36.04M	59.98M	24.34M	3.68M	5.42M	1.17M
Total Long-Term Liabilities	1.57M	6.48M	1.53M	25.87M	69.35M	16.32M	18.33M	24.23M	4.3M
Total Liabilities	15.42M	15.96M	26.21M	38.41M	77.92M	46.19M	34.51M	33.85M	7.51M
Total Debt	6.43M	5.95M	12.77M	16.76M	17.94M	32.42M	21.48M	20.75M	3.13M
Common Stock	3.06M	2.77M	1.88M	1.75M	1.02M	294K	213.72K	213.28K	193.02K
Retained Earnings	-462.88M	-419.63M	-331.16M	-296.97M	-309.69M	-146.06M	-111.22M	-79.32M	-33.58M
Comprehensive Income	-18.85M	-17.48M	137.91M	136.9M	133.22M	47.32M	25.59M	23.36M	12.67M
Shareholders Equity	60.97M	50.54M	61.87M	88M	-14.97M	40.26M	32.77M	62.48M	79.26M
Total Investments	n/a	n/a	51.1M	569K	547K	544K	2.5M	2.5M	n/a